Cibus, Inc. (NASDAQ: CBUS)

This investigation is for anyone who acquired securities in Cibus, Inc. (NASDAQ: CBUS) prior to June 4, 2024.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by overstating the benefits of the Company’s gene-editing technology.

On June 4, 2024, Bonitas Research published a report alleging, among other things, that there is “no evidence that Cibus’ gene-editing technology brings desirable new crops to market,” and, instead, there are “farmer complaints of lower crop yields and lost revenues, along with multiple examples of large seed manufacturers and distributors walking away from joint ventures and partnerships with Cibus for a variety of seed types and seed traits.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Cibus, Inc. (NASDAQ: CBUS) prior to June 4, 2024 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.